| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |